Annual CFO
-$48.97 M
-$4.87 M-11.04%
December 31, 2023
Summary
- As of March 10, 2025, IMRX annual cash flow from operations is -$48.97 million, with the most recent change of -$4.87 million (-11.04%) on December 31, 2023.
- During the last 3 years, IMRX annual CFO has fallen by -$34.35 million (-234.92%).
- IMRX annual CFO is now -1002.28% below its all-time high of -$4.44 million, reached on December 31, 2019.
Performance
IMRX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$13.47 M
-$1.95 M-16.88%
September 30, 2024
Summary
- As of March 10, 2025, IMRX quarterly cash flow from operations is -$13.47 million, with the most recent change of -$1.95 million (-16.88%) on September 30, 2024.
- Over the past year, IMRX quarterly CFO has stayed the same.
- IMRX quarterly CFO is now -482.09% below its all-time high of -$2.31 million, reached on March 31, 2020.
Performance
IMRX Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$52.26 M
-$1.45 M-2.84%
September 30, 2024
Summary
- As of March 10, 2025, IMRX TTM cash flow from operations is -$52.26 million, with the most recent change of -$1.45 million (-2.84%) on September 30, 2024.
- Over the past year, IMRX TTM CFO has stayed the same.
- IMRX TTM CFO is now -2158.22% below its all-time high of -$2.31 million, reached on March 31, 2020.
Performance
IMRX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
IMRX Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -11.0% | 0.0% | 0.0% |
| 3 y3 years | -234.9% | -14.7% | -18.5% |
| 5 y5 years | -1002.3% | -14.7% | -18.5% |
IMRX Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -58.7% | at low | -45.8% | +13.0% | -69.4% | at low |
| 5 y | 5-year | -1002.3% | at low | -482.1% | +13.0% | -2158.2% | at low |
| alltime | all time | -1002.3% | at low | -482.1% | +13.0% | -2158.2% | at low |
Immuneering Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$13.47 M(+16.9%) | -$52.26 M(+2.8%) |
| Jun 2024 | - | -$11.53 M(-25.6%) | -$50.82 M(+1.6%) |
| Mar 2024 | - | -$15.49 M(+31.6%) | -$50.04 M(+2.2%) |
| Dec 2023 | -$48.97 M(+11.0%) | -$11.78 M(-2.1%) | -$48.97 M(+0.1%) |
| Sep 2023 | - | -$12.03 M(+11.9%) | -$48.94 M(+3.0%) |
| Jun 2023 | - | -$10.75 M(-25.5%) | -$47.54 M(+2.8%) |
| Mar 2023 | - | -$14.42 M(+22.7%) | -$46.24 M(+4.8%) |
| Dec 2022 | -$44.10 M | -$11.75 M(+10.6%) | -$44.10 M(+6.0%) |
| Sep 2022 | - | -$10.62 M(+12.4%) | -$41.59 M(+4.0%) |
| Jun 2022 | - | -$9.45 M(-23.1%) | -$40.00 M(+8.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$12.28 M(+32.9%) | -$36.99 M(+19.9%) |
| Dec 2021 | -$30.85 M(+111.0%) | -$9.24 M(+2.3%) | -$30.85 M(+14.0%) |
| Sep 2021 | - | -$9.03 M(+40.3%) | -$27.06 M(+25.8%) |
| Jun 2021 | - | -$6.44 M(+4.8%) | -$21.52 M(+16.6%) |
| Mar 2021 | - | -$6.14 M(+12.6%) | -$18.45 M(+26.2%) |
| Dec 2020 | -$14.62 M(+229.1%) | -$5.45 M(+56.4%) | -$14.62 M(+59.5%) |
| Sep 2020 | - | -$3.49 M(+3.5%) | -$9.17 M(+61.4%) |
| Jun 2020 | - | -$3.37 M(+45.5%) | -$5.68 M(+145.5%) |
| Mar 2020 | - | -$2.31 M | -$2.31 M |
| Dec 2019 | -$4.44 M | - | - |
FAQ
- What is Immuneering annual cash flow from operations?
- What is the all time high annual CFO for Immuneering?
- What is Immuneering annual CFO year-on-year change?
- What is Immuneering quarterly cash flow from operations?
- What is the all time high quarterly CFO for Immuneering?
- What is Immuneering quarterly CFO year-on-year change?
- What is Immuneering TTM cash flow from operations?
- What is the all time high TTM CFO for Immuneering?
- What is Immuneering TTM CFO year-on-year change?
What is Immuneering annual cash flow from operations?
The current annual CFO of IMRX is -$48.97 M
What is the all time high annual CFO for Immuneering?
Immuneering all-time high annual cash flow from operations is -$4.44 M
What is Immuneering annual CFO year-on-year change?
Over the past year, IMRX annual cash flow from operations has changed by -$4.87 M (-11.04%)
What is Immuneering quarterly cash flow from operations?
The current quarterly CFO of IMRX is -$13.47 M
What is the all time high quarterly CFO for Immuneering?
Immuneering all-time high quarterly cash flow from operations is -$2.31 M
What is Immuneering quarterly CFO year-on-year change?
Over the past year, IMRX quarterly cash flow from operations has changed by $0.00 (0.00%)
What is Immuneering TTM cash flow from operations?
The current TTM CFO of IMRX is -$52.26 M
What is the all time high TTM CFO for Immuneering?
Immuneering all-time high TTM cash flow from operations is -$2.31 M
What is Immuneering TTM CFO year-on-year change?
Over the past year, IMRX TTM cash flow from operations has changed by $0.00 (0.00%)